Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
ApartmentLove (C.APLV) Announces Agreement with Yardi (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Antibe Therapeutics Inc T.ATE

Alternate Symbol(s):  ATBPF

Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:ATE)

Antibe Announces Results of 2023 Annual Meeting

Business Wire September 8, 2023

Toronto Stock Exchange, Antibe Therapeutics Inc., View From The C-Suite

PR Newswire August 21, 2023

Antibe Reports Q1 2024 Interim Financial and Operating Results

Business Wire August 14, 2023

Antibe Reports 2023 Year-End Results and Business Highlights

Business Wire June 29, 2023

Antibe's Chief Medical Officer to Present at the 2023 Precision in Clinical Trials Summit

Business Wire April 25, 2023

Antibe to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference

Business Wire April 18, 2023

Antibe Provides April 2023 Corporate Update

Business Wire April 11, 2023

Antibe Reports Q3 2023 Interim Financial and Operating Results

Business Wire February 15, 2023

Antibe Reports Q2 2023 Interim Financial and Operating Results

Business Wire November 15, 2022
View More News ››

Opinion & Analysis (TSX:ATE)

Buzz on the Bullboards: PyroGenesis, Antibe Top All Sectors

Omri Wallach June 18, 2020

Buzz on the Bullboards: Healthcare Falls, Cannabis and Energy Rise

Omri Wallach June 11, 2020

Buzz on the Bullboards: Stocks Poised for Coronavirus Recovery?

Omri Wallach February 27, 2020

Buzz on the Bullboards: The Rebound Season?

Omri Wallach December 5, 2019

Top Pick Status Given to Small-Cap with Pain Drug Candidate

Streetwise Reports July 19, 2019

Buzz on the Bullboards: Investing Success in 2019?

Stockhouse Editorial January 11, 2019
View More Opinion ››

Bullboard Posts (TSX:ATE)

RE:Nice lift by Solena

We could have similar success - but I'm hoping we get it right on acute and then they provide a direction for chronic ... all in 2024...
MrMugsy - 1 day ago

Nice lift by Solena

Solena uo 500% today, foreshadowing of Antibe success for Acute?
baggerx99 - 1 day ago

Might get another chance

to add shares in the mid 40's. these dips have been bought up last 2 days in a row and then flipped on negative market sentiment that...
Duster340 - 1 day ago

September Corp Presentation

Updated on the Corporate Site.  Nothing newsworthy - confirmation of existing dates and small language tweeks.  No change to...
Harper75 - 1 day ago

RE:Grant of options

Duster - just remember - so much attention is put on penny movements up and penny movement down with ATE on these social media sites...
MrMugsy - 3 days ago

Grant of options

ok so 56 cents was the actual price of the stock when the company was handing out these grant options. what i am wondering is what are...
Duster340 - 6 days ago
View more Bullboard ››

Permex Petroleum Corp

Permex Petroleum Corp

Permex Petroleum Corporation is a junior oil and gas company. The Company is engaged in the acquisition, exploration ...
View More »